Navigation Links
Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Association's 69th Scientific Sessions
Date:6/1/2009

- Late-Breaking Abstract Accepted -

SAN DIEGO, June 1, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that a late-breaking abstract of its lorcaserin Phase 3 BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) trial has been accepted for a poster presentation at the American Diabetes Association's 69th Scientific Sessions in New Orleans, Louisiana. The abstract, titled "Lorcaserin Reduces Body Weight in Obese and Overweight Subjects: Behavioral Modification and Lorcaserin for Overweight and Obesity Management, the BLOOM Trial," will be displayed from June 6, 2009 at 10:00 a.m. Central Daylight Time (CDT) until June 8, 2009 at 4:00 p.m. CDT in the Morial Convention Center, Hall E. The poster has been assigned presentation number 96-LB in category 20-B Obesity - Clinical Treatment.

Steven R. Smith, M.D., BLOOM Co-Principal Investigator and Professor and Assistant Director for Clinical Research at the Pennington Biomedical Research Center; William R. Shanahan, M.D., Arena's Vice President and Chief Medical Officer; and Christen M. Anderson, M.D., Ph.D., Arena's Vice President, Clinical Development, will be available at the poster to discuss and address questions during two periods:

- Sunday, June 7, 2009: 6:30-7:45 p.m. CDT

- Monday, June 8, 2009: 12:00-2:00 p.m. CDT

About Lorcaserin

Lorcaserin is a novel single agent that represents the first in a new class of selective serotonin 2C receptor agonists. The serotonin 2C receptor is located in areas of the brain involved in the control of appetite and metabolism, such as the hypothalamus. Stimulation of this receptor is strongly associated with feeding behavior and satiety. Lorcaserin is currently being evaluated in a Phase 3 pro
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014  Decision Resources Group finds that ... (ID) specialists are willing to prescribe Durata,s Dalvance ... use as OPAT, approximately two-thirds of the respondents ... their hospital inpatients. However, our findings indicate that ... initiated on OPAT following hospital discharge, and most ...
(Date:1/15/2014)... /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from ... China,s orthopedic instrument industry has seen ... rising from 3.28 billion yuan in 2006 to 9.85 ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health ... several new IT value-added reseller (VAR) national contracts that ... goods and services at lower costs. These include manufacturer ... such as initiative assistance and ongoing IT consulting support. ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2
(Date:7/10/2014)... than 200 experts on aggression, who research issues ranging ... the 21st World Meeting of the International Society ... Atlanta Hotel, July 15-19. , Georgia State University ... held every other year on alternating continents. , "We ... more than 20 different countries, which will help produce ...
(Date:7/10/2014)... Ticketability.com has a wide array of tickets ... tickets for San Diego are being added to the inventory. ... and the newly added September 28 show is drawing a ... Here to view the selection of discounted seats at ... become available to the general public on July 18 at ...
(Date:7/10/2014)... 2014 One week ahead of its ... announced today it will extend compensation benefits to workers ... for workers displaced as a result of factory remediation, ... have resulted in the closure of five factories for ... raising immediate safety concerns. In May, the Alliance—in a ...
(Date:7/10/2014)... 11, 2014 According to a ... by Platforms (Land, Airborne, Naval), Application (Software Defined ... by Geography (North America, Asia-Pacific, Europe, the Middle ... published by MarketsandMarkets, the market is estimated to ... to register a CAGR of 5.56% to reach ...
(Date:7/10/2014)... In his latest blog post at ... facility CEO Per Wickstrom has listed 5 ways to ... confirm an appointment, get information or sometimes even just ... being annoying is a skill that most people don’t ... to keep the dialogue moving without coming across as ...
Breaking Medicine News(10 mins):Health News:Georgia State Hosts National Conference On Aggression 2Health News:Georgia State Hosts National Conference On Aggression 3Health News:Georgia State Hosts National Conference On Aggression 4Health News:Paul McCartney Tickets for San Diego: Ticketability.com Announces Discounted Tickets for McCartney’s Tour Stop at Petco Park on September 28 2Health News:Alliance for Bangladesh Worker Safety to Double Compensation for Displaced Factory Workers; Members Vote to Extend Wage Benefits from Two to up to Four Months 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Per Wickstrom’s Latest Blog Post Lists 5 Ways to Follow-up Without Being Annoying 2
... available everywhere in the Wadden Sea so you have to search ... where is the best place to go? Initially the food rich ... can find other animals of course and that gives rise to ... to consume the prey caught. , Takeaway meal , ...
... leading cause of adult-onset blindness, experts note , TUESDAY, Sept. ... their vision checked if they have access to health care, ... experts say. , However, minorities with diabetes or people living ... even when they know why it is important to do ...
... magnetic resonance imaging (fMRI) have found a new marker ... according to a study published in the October issue ... a potential functional, rather than structural, brain markerseparate from ... Alzheimers patients, said the studys lead author, Jeffrey R. ...
... BOTHELL, Wash., Sept. 25 Cardiac Science,Corporation ... in advanced cardiac monitoring,and defibrillation products, today ... other lay rescuers from the Pittsburgh school ... defibrillator,(AED). (Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO ) ...
... for research to improve health and welfare of ... companion animals and wildlife, ... for individuals or groups to demonstrate love,for and help animals via ... about 120 animal health studies available,for sponsorship. Animal lovers are invited ...
... ... Program Oct. 1, MINNEAPOLIS and ST. PAUL, ... Minnesota,s major health plans and,ClearWay Minnesota(SM) -- is launching a new program ... patients who,want to stop smoking. The Minnesota Clinic Fax Referral Program begins,October ...
Cached Medicine News:Health News:Regular Eye Screens Spot Diabetic Vision Trouble 2Health News:Radiologists identify early brain marker of Alzheimer's disease 2Health News:Radiologists identify early brain marker of Alzheimer's disease 3Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 2Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 3Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 4Health News:Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies 2Health News:Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies 3Health News:Health Organizations Join Forces Around Quit-Smoking Help 2
Nasal Implants are used to augment the shape or reshaping of the nose....
... PTFE facial implant is an expanded ... augmentation or repair of the soft ... is available in sheets and shaped ... round facial implant strands are packaged ...
Inquire...
The MiniMed Paradigm REAL-Time System is the world's first system to integrate an insulin pump with REAL-Time continuous glucose monitoring, taking diabetes management to a level you just can't achie...
Medicine Products: